AAAAAA
Results: 726-750/15678
Authors:
Akagi, R
Shimizu, R
Furuyama, K
Doss, MO
Sassa, S
Citation: R. Akagi et al., Novel molecular defects of the delta-aminolevulinate dehydratase gene in apatient with inherited acute hepatic porphyria, HEPATOLOGY, 31(3), 2000, pp. 704-708
Authors:
Hermenegildo, C
Monfort, P
Felipo, V
Citation: C. Hermenegildo et al., Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: Characterization by in vivo brain microdialysis, HEPATOLOGY, 31(3), 2000, pp. 709-715
Authors:
Erhardt, A
Reineke, U
Blondin, D
Gerlich, WH
Adams, O
Heintges, T
Niederau, C
Haussinger, D
Citation: A. Erhardt et al., Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B, HEPATOLOGY, 31(3), 2000, pp. 716-725
Authors:
Martinot-Peignoux, M
Boyer, N
Le Breton, V
Le Guludec, G
Castelnau, C
Akremi, R
Marcellin, P
Citation: M. Martinot-peignoux et al., A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C, HEPATOLOGY, 31(3), 2000, pp. 726-729
Authors:
Fontana, RJ
Israel, J
LeClair, P
Banner, BF
Tortorelli, K
Grace, N
Levine, RA
Fiarman, G
Thiim, M
Tavill, AS
Bonkovsky, HL
Citation: Rj. Fontana et al., Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial, HEPATOLOGY, 31(3), 2000, pp. 730-736
Authors:
Schmidt, WN
Stapleton, JT
LaBrecque, DR
Mitros, FA
Kirby, PA
Phillips, MJP
Brashear, DL
Citation: Wn. Schmidt et al., Hepatitis C virus (HCV) infection and cryoglobulinemia: Analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology, HEPATOLOGY, 31(3), 2000, pp. 737-744
Authors:
Nagayama, K
Kurosaki, M
Enomoto, N
Miyasaka, Y
Marumo, F
Sato, C
Citation: K. Nagayama et al., Characteristics of hepatitis C viral genome associated with disease progression, HEPATOLOGY, 31(3), 2000, pp. 745-750
Authors:
Conte, D
Fraquelli, M
Prati, D
Colucci, A
Minola, E
Citation: D. Conte et al., Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women, HEPATOLOGY, 31(3), 2000, pp. 751-755
Authors:
Murphy, EL
Bryzman, SM
Glynn, SA
Ameti, DI
Thomson, RA
Williams, AE
Nass, CC
Ownby, HE
Schreiber, GB
Kong, FH
Neal, KR
Nemo, GJ
Citation: El. Murphy et al., Risk factors for hepatitis C virus infection in United States blood donors, HEPATOLOGY, 31(3), 2000, pp. 756-762
Authors:
Chan, HLY
Leung, NWY
Hussain, M
Wong, ML
Lok, ASF
Citation: Hly. Chan et al., Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong, HEPATOLOGY, 31(3), 2000, pp. 763-768
Authors:
Macejak, DG
Jensen, KL
Jamison, SF
Domenico, K
Roberts, EC
Chaudhary, N
von Carlowitz, I
Bellon, L
Tong, MJ
Conrad, A
Pavco, PA
Blatt, LM
Citation: Dg. Macejak et al., Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes, HEPATOLOGY, 31(3), 2000, pp. 769-776
Authors:
Armstrong, GL
Alter, MJ
McQuillan, GM
Margolis, HS
Citation: Gl. Armstrong et al., The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States, HEPATOLOGY, 31(3), 2000, pp. 777-782
Authors:
Mezey, E
Citation: E. Mezey, Insulin growth factor I and hypogonadism in cirrhosis, HEPATOLOGY, 31(3), 2000, pp. 783-784
Authors:
Yen, TSB
Citation: Tsb. Yen, Nuclear factor kappa B and hepatitis C - Is there a connection?, HEPATOLOGY, 31(3), 2000, pp. 785-787
Authors:
Gretch, D
Citation: D. Gretch, Standardization of hepatitis C virus-RNA quantification: Advances and unfinished business, HEPATOLOGY, 31(3), 2000, pp. 788-789
Authors:
Thomas, DL
Citation: Dl. Thomas, Hepatitis C epidemiology: Injecting new tools in the field, HEPATOLOGY, 31(3), 2000, pp. 790-791
Authors:
Kim, WR
Poterucha, JJ
Gross, JB
Citation: Wr. Kim et al., Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment ofchronic hepatitis C, HEPATOLOGY, 31(3), 2000, pp. 807-807
Authors:
Younossi, ZM
Singer, ME
McHutchison, JG
Shermock, KM
Citation: Zm. Younossi et al., Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment ofchronic hepatitis C - Reply, HEPATOLOGY, 31(3), 2000, pp. 807-808
Authors:
Zein, NN
Perez, RG
Wiesner, RH
Citation: Nn. Zein et al., Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation, HEPATOLOGY, 31(3), 2000, pp. 808-809
Authors:
Hezode, C
Dhumeaux, D
Pawlotsky, JM
Citation: C. Hezode et al., Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation - Reply, HEPATOLOGY, 31(3), 2000, pp. 809-809
Authors:
Forrest, E
Stanley, A
Hayes, P
Citation: E. Forrest et al., Carvedilol - A new nonselective beta blocker, HEPATOLOGY, 31(3), 2000, pp. 809-810
Authors:
Banares, R
Moitinho, E
Bosch, J
Citation: R. Banares et al., Carvedilol - A new nonselective beta blocker - Reply, HEPATOLOGY, 31(3), 2000, pp. 810-811
Authors:
Manns, MP
Citation: Mp. Manns, Hepatitis C and autoimmune hepatitis, HEPATOLOGY, 31(3), 2000, pp. 811-811
Authors:
Cerny, A
Kammer, AR
Chisari, FV
Citation: A. Cerny et al., Hepatitis C and autoimmune hepatitis - Reply, HEPATOLOGY, 31(3), 2000, pp. 811-812
Authors:
Jamal
Citation: Jamal, Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the southwestern United States (vol 30, pg1307, 1999), HEPATOLOGY, 31(3), 2000, pp. 813-813